[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2500292T3 - Camsilato de amlodipina amorfo, estable, procedimiento para la reparación del mismo y composición para su administración oral - Google Patents

Camsilato de amlodipina amorfo, estable, procedimiento para la reparación del mismo y composición para su administración oral Download PDF

Info

Publication number
ES2500292T3
ES2500292T3 ES04705547.0T ES04705547T ES2500292T3 ES 2500292 T3 ES2500292 T3 ES 2500292T3 ES 04705547 T ES04705547 T ES 04705547T ES 2500292 T3 ES2500292 T3 ES 2500292T3
Authority
ES
Spain
Prior art keywords
camsilate
stable
composition
oral administration
repair procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04705547.0T
Other languages
English (en)
Inventor
Young Ho Moon
Nam Du Kim
Kyung Ik Lee
Gwan Sun Lee
Jong Soo Woo
Young Kil Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Science Co Ltd
Original Assignee
Hanmi Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36147033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2500292(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Science Co Ltd filed Critical Hanmi Science Co Ltd
Application granted granted Critical
Publication of ES2500292T3 publication Critical patent/ES2500292T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
    • E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
    • E06B5/00—Doors, windows, or like closures for special purposes; Border constructions therefor
    • E06B5/10—Doors, windows, or like closures for special purposes; Border constructions therefor for protection against air-raid or other war-like action; for other protective purposes
    • E06B5/16—Fireproof doors or similar closures; Adaptations of fixed constructions therefor
    • E06B5/161—Profile members therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2255/00—Coating on the layer surface
    • B32B2255/08—Coating on the layer surface on wood layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2307/00—Properties of the layers or laminate
    • B32B2307/30—Properties of the layers or laminate having particular thermal properties
    • B32B2307/306—Resistant to heat
    • B32B2307/3065—Flame resistant or retardant, fire resistant or retardant
    • E—FIXED CONSTRUCTIONS
    • E05—LOCKS; KEYS; WINDOW OR DOOR FITTINGS; SAFES
    • E05Y—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES E05D AND E05F, RELATING TO CONSTRUCTION ELEMENTS, ELECTRIC CONTROL, POWER SUPPLY, POWER SIGNAL OR TRANSMISSION, USER INTERFACES, MOUNTING OR COUPLING, DETAILS, ACCESSORIES, AUXILIARY OPERATIONS NOT OTHERWISE PROVIDED FOR, APPLICATION THEREOF
    • E05Y2900/00—Application of doors, windows, wings or fittings thereof
    • E05Y2900/10—Application of doors, windows, wings or fittings thereof for buildings or parts thereof
    • E05Y2900/13—Type of wing
    • E05Y2900/132—Doors
    • E05Y2900/134—Fire doors

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Camsilato de amlodipina amorfo, preparado por disolución de camsilato de amlodipina cristalino en un disolvente orgánico seleccionado entre el grupo que comprende acetona, metanol, etanol, acetonitrilo, tetrahidrofurano, dioxano, acetato de metilo, acetato de etilo, cloruro de metileno, cloroformo y una mezcla de los mismos, y eliminando el disolvente de la solución resultante.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES04705547.0T 2003-01-27 2004-01-27 Camsilato de amlodipina amorfo, estable, procedimiento para la reparación del mismo y composición para su administración oral Expired - Lifetime ES2500292T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR2003005227 2003-01-27
KR20030005227 2003-01-27
PCT/KR2004/000136 WO2004067512A1 (en) 2003-01-27 2004-01-27 Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof

Publications (1)

Publication Number Publication Date
ES2500292T3 true ES2500292T3 (es) 2014-09-30

Family

ID=36147033

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04705547.0T Expired - Lifetime ES2500292T3 (es) 2003-01-27 2004-01-27 Camsilato de amlodipina amorfo, estable, procedimiento para la reparación del mismo y composición para su administración oral

Country Status (9)

Country Link
US (1) US20060128763A1 (es)
EP (1) EP1587792B1 (es)
JP (1) JP2007528349A (es)
KR (1) KR100558505B1 (es)
CN (1) CN1777586A (es)
BR (1) BRPI0407038A (es)
ES (1) ES2500292T3 (es)
MX (1) MXPA05007876A (es)
WO (1) WO2004067512A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100742432B1 (ko) * 2005-12-27 2007-07-24 한미약품 주식회사 암로디핀 캠실레이트 및 심바스타틴을 포함하는 복합제제,및 이의 제조방법
KR100913791B1 (ko) * 2006-07-21 2009-08-26 한미약품 주식회사 (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
KR100821688B1 (ko) 2006-08-10 2008-04-11 (주)유케이케미팜 암로디핀 라셈화물의 입체이성질체의 분리방법과 그의친수성 약물 및 그의 제조방법
KR101247583B1 (ko) * 2006-12-08 2013-03-26 한미사이언스 주식회사 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물
MX349221B (es) 2009-01-23 2017-07-19 Hanmi Science Co Ltd * Composicion farmaceutica solida que comprende amlodipina y losartan y procesos para producir la misma.
EP3039011A1 (en) * 2013-08-29 2016-07-06 Cadila Healthcare Limited Polymorphic form of pyrrole derivative and intermediate thereof
JP6339364B2 (ja) * 2013-12-27 2018-06-06 カズマパートナーズ株式会社 無定形ブリモニジン酒石酸塩及びその製造方法
CN116332832A (zh) * 2023-03-29 2023-06-27 安徽美致诚药业有限公司 一种马来酸左旋氨氯地平无定型晶型及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
KR950007228B1 (ko) 1987-08-05 1995-07-07 화이자 인코포레이티드 암로디핀의 베실레이트염
KR100363566B1 (ko) * 1998-11-20 2003-08-19 국제약품공업주식회사 무정형 세푸록심 악세틸의 제조방법
EP1309557B9 (en) * 2000-12-29 2006-11-15 Pfizer Limited Amlodipine hemimaleate
CZ20031779A3 (cs) * 2000-12-29 2004-10-13 Bioorganicsáb@V Způsob přípravy amlodipinuŹ jeho derivátů a jejich prekurzorů
WO2002053538A1 (en) * 2000-12-29 2002-07-11 Pfizer Limited Amlodipine fumarate
DE10112764A1 (de) * 2001-03-16 2002-09-19 Mann & Hummel Filter Radialverdichter
KR100452491B1 (ko) * 2001-03-29 2004-10-12 한미약품 주식회사 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.

Also Published As

Publication number Publication date
BRPI0407038A (pt) 2006-01-17
WO2004067512A1 (en) 2004-08-12
US20060128763A1 (en) 2006-06-15
EP1587792A4 (en) 2011-03-09
EP1587792A1 (en) 2005-10-26
CN1777586A (zh) 2006-05-24
KR20040068877A (ko) 2004-08-02
MXPA05007876A (es) 2005-09-21
JP2007528349A (ja) 2007-10-11
KR100558505B1 (ko) 2006-03-07
EP1587792B1 (en) 2014-08-27

Similar Documents

Publication Publication Date Title
EP2372455A3 (en) Photoacid generators and photoresists comprising the same
ES2555781T3 (es) Aceites vegetales epoxidados como plastificantes de PVC
ES2654395T3 (es) Análogos de amilorida espirocíclicos como bloqueantes de ENaC
ES2524784T3 (es) Formas polimórficas de un inhibidor macrocíclico del VHC
ES2500292T3 (es) Camsilato de amlodipina amorfo, estable, procedimiento para la reparación del mismo y composición para su administración oral
CR11750A (es) Pirimidin-5-carboxamidas sustituidas 281
ECSP056023A (es) Métodos para aislar la forma cristalina I de la 5-azacitidina
ECSP109856A (es) Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842
AR057728A1 (es) Piperazinas sustituidas como antagonistas de receptores de glutamato metabotropicos. composiciones farmaceuticas.
CU20100238A7 (es) Derivados de isoxazol y su uso como potenciadores de los receptores metabotrópicos de glutamato
AR054365A1 (es) Derivados de heteroaril benzamidas, composiciones farmaceuticas que los contienen, usos en enfermedades mediadas por glucoquinasasy metodo de preparacion de los mismos.
NO20063380L (no) Triazolderivater som vasopressinantagonister
ECSP055633A (es) Nuevos derivados de benzoimidazolutiles como angentes antiproliferativos
UY29427A1 (es) Derivados sustituidos de 2,3,4,5- tetrahidro-1h-pirido (4,3-b) indol, composiciones que los contienen, procesos de preparación y aplicaciones
AR055616A1 (es) Compuestos de tiofeno bencimidazol
EP1591120A4 (en) RECEPTOR AGONISTS
ECSP088114A (es) Nuevos derivados de la 2-azetidinona y su uso como inhibidores de absorción del colesterol para el tratamiento de hiperlipidemia
EP2332960A3 (en) Cholate photoacid generators and photoresists comprising same
UY29896A1 (es) Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
AR061151A1 (es) Formas cristalinas de 11beta - (4 - acetilfenil) - 20, 20, 21, 21, 21 - pentafluoro - 17 - hidroxi - 19 - nor - 17alfa - pregna - 4, 9 - dien - 3 - ona, metodos para su obtencion y preparaciones farmaceuticas que las contienen para emplear en el tratamiento de miomas y cancer de mamas.
ATE502936T1 (de) 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
ATE466008T1 (de) P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
UY27979A1 (es) Indoles sustituidos en posición 2,4